163 related articles for article (PubMed ID: 27250582)
1. Activation of liver X receptor inhibits the development of pulmonary carcinomas induced by 3-methylcholanthrene and butylated hydroxytoluene in BALB/c mice.
Wang Q; Sun L; Yang X; Ma X; Li Q; Chen Y; Liu Y; Zhang D; Li X; Xiang R; Wei Y; Han J; Duan Y
Sci Rep; 2016 Jun; 6():27295. PubMed ID: 27250582
[TBL] [Abstract][Full Text] [Related]
2. Strain-dependent lung tumor formation in mice transplacentally exposed to 3-methylcholanthrene and post-natally exposed to butylated hydroxytoluene.
Gressani KM; Leone-Kabler S; O'Sullivan MG; Case LD; Malkinson AM; Miller MS
Carcinogenesis; 1999 Nov; 20(11):2159-65. PubMed ID: 10545420
[TBL] [Abstract][Full Text] [Related]
3. Butylated hydroxytoluene exposure is necessary to induce lung tumors in BALB mice treated with 3-methylcholanthrene.
Malkinson AM; Koski KM; Evans WA; Festing MF
Cancer Res; 1997 Jul; 57(14):2832-4. PubMed ID: 9230183
[TBL] [Abstract][Full Text] [Related]
4. Neutrophils are required for 3-methylcholanthrene-initiated, butylated hydroxytoluene-promoted lung carcinogenesis.
Vikis HG; Gelman AE; Franklin A; Stein L; Rymaszewski A; Zhu J; Liu P; Tichelaar JW; Krupnick AS; You M
Mol Carcinog; 2012 Dec; 51(12):993-1002. PubMed ID: 22006501
[TBL] [Abstract][Full Text] [Related]
5. Cell kinetics in mouse lung following administration of carcinogens and butylated hydroxytoluene.
Witschi HP; Morse CC
Toxicol Appl Pharmacol; 1985 May; 78(3):464-72. PubMed ID: 4049395
[TBL] [Abstract][Full Text] [Related]
6. Encapsulation of LXR ligand by D-Nap-GFFY hydrogel enhances anti-tumorigenic actions of LXR and removes LXR-induced lipogenesis.
Feng K; Ma C; Liu Y; Yang X; Yang Z; Chen Y; Xu T; Yang C; Zhang S; Li Q; Wei Z; Zhao D; Zeng P; Han J; Gao J; Chen Y; Duan Y
Theranostics; 2021; 11(6):2634-2654. PubMed ID: 33456564
[No Abstract] [Full Text] [Related]
7. Inhibition of tumor growth by U0126 is associated with induction of interferon-γ production.
Ma X; Wang Q; Liu Y; Chen Y; Zhang L; Jiang M; Li X; Xiang R; Miao RQ; Duan Y; Han J
Int J Cancer; 2015 Feb; 136(4):771-83. PubMed ID: 24947959
[TBL] [Abstract][Full Text] [Related]
8. Identification of interferon-γ as a new molecular target of liver X receptor.
Wang Q; Ma X; Chen Y; Zhang L; Jiang M; Li X; Xiang R; Miao R; Hajjar DP; Duan Y; Han J
Biochem J; 2014 Apr; 459(2):345-54. PubMed ID: 24438183
[TBL] [Abstract][Full Text] [Related]
9. Modification of lung tumor growth by hyperoxia.
Lindenschmidt RC; Margaretten N; Griesemer RA; Witschi HP
Carcinogenesis; 1986 Sep; 7(9):1581-6. PubMed ID: 3742730
[TBL] [Abstract][Full Text] [Related]
10. Quantitative trait locus mapping of susceptibilities to butylated hydroxytoluene-induced lung tumor promotion and pulmonary inflammation in CXB mice.
Malkinson AM; Radcliffe RA; Bauer AK
Carcinogenesis; 2002 Mar; 23(3):411-7. PubMed ID: 11895855
[TBL] [Abstract][Full Text] [Related]
11. Mutations of the Ki-ras protooncogene in 3-methylcholanthrene and urethan-induced and butylated hydroxytoluene-promoted lung tumors of strain A/J and SWR mice.
Wang X; Witschi H
Cancer Lett; 1995 May; 91(1):33-9. PubMed ID: 7750092
[TBL] [Abstract][Full Text] [Related]
12. Compensatory lung growth after partial pneumonectomy enhances lung tumorigenesis induced by 3-methylcholanthrene.
Brown LM; Malkinson AM; Rannels DE; Rannels SR
Cancer Res; 1999 Oct; 59(20):5089-92. PubMed ID: 10537279
[TBL] [Abstract][Full Text] [Related]
13. Lung toxicity and tumor promotion by hydroxylated derivatives of 2,6-di-tert-butyl-4-methylphenol (BHT) and 2-tert-butyl-4-methyl-6-iso-propylphenol: correlation with quinone methide reactivity.
Kupfer R; Dwyer-Nield LD; Malkinson AM; Thompson JA
Chem Res Toxicol; 2002 Aug; 15(8):1106-12. PubMed ID: 12184795
[TBL] [Abstract][Full Text] [Related]
14. Strain-related differences in the pneumotoxic effects of chronically administered butylated hydroxytoluene on protein kinase C and calpain.
Miller AC; Dwyer LD; Auerbach CE; Miley FB; Dinsdale D; Malkinson AM
Toxicology; 1994 May; 90(1-2):141-59. PubMed ID: 8023339
[TBL] [Abstract][Full Text] [Related]
15. Separation of early diffuse alveolar cell proliferation from enhanced tumor development in mouse lung.
Witschi HP
Cancer Res; 1986 Jun; 46(6):2675-9. PubMed ID: 3698002
[TBL] [Abstract][Full Text] [Related]
16. Differential sensitivity to lung tumorigenesis following transplacental exposure of mice to polycyclic hydrocarbons, heterocyclic amines, and lung tumor promoters.
Miller MS; Gressani KM; Leone-Kabler S; Townsend AJ; Malkinson AM; O'Sullivan MG
Exp Lung Res; 2000 Dec; 26(8):709-30. PubMed ID: 11195466
[TBL] [Abstract][Full Text] [Related]
17. Two-stage 3-methylcholanthrene and butylated hydroxytoluene-induced lung carcinogenesis in mice.
Bauer AK; Dwyer-Nield LD
Methods Cell Biol; 2021; 163():153-173. PubMed ID: 33785163
[TBL] [Abstract][Full Text] [Related]
18. Enhanced tumour development by butylated hydroxytoluene (BHT) in the liver, lung and gastro-intestinal tract.
Witschi HP
Food Chem Toxicol; 1986; 24(10-11):1127-30. PubMed ID: 3804115
[TBL] [Abstract][Full Text] [Related]
19. Pharmacologic and genetic studies on the modulatory effects of butylated hydroxytoluene on mouse lung adenoma formation.
Malkinson AM; Beer DS
J Natl Cancer Inst; 1984 Oct; 73(4):925-33. PubMed ID: 6592388
[TBL] [Abstract][Full Text] [Related]
20. The lung tumor promoter, butylated hydroxytoluene (BHT), causes chronic inflammation in promotion-sensitive BALB/cByJ mice but not in promotion-resistant CXB4 mice.
Bauer AK; Dwyer-Nield LD; Hankin JA; Murphy RC; Malkinson AM
Toxicology; 2001 Dec; 169(1):1-15. PubMed ID: 11696405
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
